Navigation Links
MedCom Announces Court Rules Card Activation Technologies' Patent Is Valid
Date:3/20/2008

SCOTTSDALE, Ariz., March 20 /PRNewswire-FirstCall/ -- MedCom USA, Inc. (OTC Bulletin Board: EMED), a leading provider of HIPAA compliant healthcare and financial transaction solutions for the healthcare industry owning approximately 40% of the issued shares of Card Activation Technologies (OTC Bulletin Board: CDVT), announced today that the United States District Court for the Northern District of Illinois ruled that Card Activation's Patent, U.S. Patent Number 6,032,859, is valid.

Card Activation Technologies is the owner of the patent covering a method for the activation and processing of transactions related to debit styled cards, which include gift cards, phone cards and other stored value cards The court issued its ruling in response to a motion to declare the patent invalid that was filed by Barnes & Noble Inc. (NYSE: BKS) and Aeropostale Inc. (NYSE: ARO).

MedCom will soon issue full details of the court's ruling.

MedCom (http://www.medcomusa.com) spun out Card Activation Technologies in 2006 into a separate trading company due to the huge potential for licensing of the company's technology in the prepaid card market. Card Activation Technologies, Inc. is a Chicago-based company that owns proprietary patented payment transaction technology used for processing gift cards, phone cards and other debit purchase transactions. The Company is actively seeking to license its technology to the thousands of current users and believes that many retailers, gas stations, phone companies and others that utilize those stored value cards, such as gift and debit, infringe its patent. As a result, the company is aggressively pursuing litigation against these infringements. The Federal Reserve Bank of Philadelphia estimated the prepaid card market to be valued in excess of $181.7 billion in transactions in 2006. According to market forecasts, the prepaid industry will grow to $421.5 Billion by 2010. For further information about Card Activation Technologies go to http://www.cardactivationtech.com .

Certain statements in this press release that are not historical facts are "forward-looking statements" within the meaning of the Private Securities Litigation Reform Act of 1995. Such statements may be identified by the use of words such as "anticipate," "believe," "expect," "future," "may," "will," "would," "should," "plan," "projected," "intend," and similar expressions. Such forward-looking statements involve known and unknown risks, uncertainties and other factors that may cause the actual results, performance or achievements of Card Activation Technologies, Inc. (the Company) to be materially different from those expressed or implied by such forward-looking statements. The Company's future operating results are dependent upon many factors, including but not limited to the Company's ability to: (i) defend its patent; (ii) build the management and human resources and infrastructure necessary to support the growth of its business; (iii) competitive factors and developments beyond the Company's control; and (iv) other risk factors discussed in the Company's periodic filings with the Securities and Exchange Commission, which are available for review at http://www.sec.gov under "Search for Company Filings."

Contacts for Card Activation Technologies

Bev Jedynak Paul Knopick

Martin E. Janis & Company Inc. E & E Communications

312-943-1123 (949) 707-5365

bjedynak@janispr.com pknopick@eandecommunications.com


'/>"/>
SOURCE MedCom USA, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Related medicine news :

1. MedCom USA Signs Southwood Medical Marketing to Distribute MedCom System
2. MedcomSoft Receives 2007s "Best in KLAS" EMR Ranking (1-5 Physicians)
3. MedcomSoft appoints former U.S. presidential health advisor, James Haveman, to health Care advisory board
4. MedCom USAs Subsidiary Card Activation Technologies, Inc.s SB2 Registration Declared Effective by SEC
5. Patrick G. Ryan Announces Intention to Retire from Aon
6. Pregis Announces Fouth Quarter and Full Year 2007 Financial Results
7. Takeda Announces New U.S. Leadership
8. QED International Associates Announces Quarterly Rebalancing of HealthShares(TM) Indexes
9. Galderma Announces HSR Clearance for Its Proposal to Acquire CollaGenex Pharmaceuticals
10. The Pennsylvania Breast Cancer Coalition Announces Event at the University of Pennsylvania Hospital to Celebrate the 2008 Income Tax Check-Off Campaign
11. Law Offices of Howard G. Smith Announces Class Action Lawsuit Against Vertex Pharmaceuticals Incorporated
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/24/2017)... ... March 24, 2017 , ... According to a new ... invalid because it does not obey the rules Congress has directed the CBO to ... which the GOP reform would restore. Yet, it estimates a reduction in employer-based coverage ...
(Date:3/24/2017)... , ... March 24, 2017 , ... ... Sedona, Arizona’s Premier Center for Shamanic Healing and Spiritual Awakening, proudly presents ... June 9--24, 2017. This sacred and spiritual journey during the Summer Solstice ...
(Date:3/24/2017)... ... March 24, 2017 , ... ... the Advanced ERISA Benefit Claims Litigation seminar in Chicago, Illinois. She will ... The majority of cases litigated under ERISA involve claims for long-term disability benefits. ...
(Date:3/24/2017)... ... 24, 2017 , ... Empower Brokerage, located in Southlake, Texas, ... programs. , In February, 2017, Empower Brokerage introduced their new “Performance Partners” program ... to teach how to maximize their sales efforts, as well as how to ...
(Date:3/24/2017)... ... ... “Vintage and Harvest A Cultivation of Christian Love” is the creation of published ... with his wife, Anna Marie. He and his wife are the proud parents of ... author of “Shadow and Substance.” , “Love, the agape kind, is seen as more ...
Breaking Medicine News(10 mins):
(Date:3/24/2017)... March 24, 2017 ShangPharma, a ... and cost-effective drug development and discovery services, ... biotechnology industry, announced today the intent for ... will be consolidating the Contract Research Organizations ... Shanghai ChemPartner. These entities include ChemPartner Shanghai, ...
(Date:3/24/2017)... India , March 24, 2017 A ... market has been growing rapidly as the global sales of Adcetris ... the growth in the antibody drug conjugates market is driven by ... of cancer and wider therapeutic window offered by ADCs. ... Browse 3 Tables and 94 ...
(Date:3/24/2017)... , March 24, 2017  Eli Lilly and ... plans to invest $850 million in its U.S. ... across its U.S. enterprise, including research laboratories, manufacturing ... are being driven by demand for Lilly products, ... medicines in development targeting cancer, pain, diabetes and ...
Breaking Medicine Technology: